What is
Walking pneumonia means a person with pneumonia is highly likely to get well at home and not develop complications. Still, walking pneumonia is considered a significant infection and requires promp…
Related Articles
Advancing Radiopharmaceuticals: From Lead-212 to Pre-Targeting Strategies – Michael Schultz
Oliver Sartor speaks with Michael Schultz about advances in radiopharmaceuticals for cancer treatment. Dr. Schultz discusses the advantages of using alpha-particle emitters, particularly lead-212, for…
home
CDC – Blogs – NCHS: A Blog of the National Center for Health Statistics – NCHS Recognizes National Rural Health Day – Featured Topics from…
Existing high blood pressure drugs may prevent epilepsy, Stanford Medicine-led study finds
In an analysis of more than 2 million patient records, researchers discovered that people taking angiotensin receptor blockers for high blood pressure were less likely…
ASHG members research highlights: Cell Press
A research collection from ASHG journals that celebrates important genetics and genomics discoveries from ASHG members.
Interaction molecular QTL mapping discovers cellular and environmental modifiers of genetic regulatory effects
To identify regulatory variants with plasticity in effect size, we performed interaction molecular quantitative trait loci (iQTL) mapping with cell-type abundance, age, sex, and smoking…
Comparing PSMA Ligands for Prostate Cancer Imaging – Michael Hofman
Alicia Morgans discusses advances in prostate cancer imaging and theranostics with Michael Hofman. Dr. Hofman emphasizes the growing variety of PSMA ligands for PET-CT imaging…
Wall Street awaits Amgen weight-loss drug data expected to move shares
Upcoming data from a mid-stage study of Amgen’s experimental weight-loss drug MariTide will shed light on how well it might measure up against the popular…
Environment and Context in PA, Sedentary Behaviour and Sleep Research – Dr Bruno da Costa (Pt 2) | Physical Activity Researcher
Announcement Related to the Rest of the 2022 – Irregular Publishing Schedule Dear listeners, So it happened that both of the podcast hosts became parents…
Elon Musk’s Neuralink receives Canadian approval for brain chip trial
Elon Musk’s Neuralink said on Wednesday it has received approval to launch its first clinical trial in Canada for a device designed to give paralysed…
Pharmalittle: We’re reading about Trump and tariff worries, PBM rules in New York, and more
Some industry leaders are confident health care products such as drugs will be carved out of expected Trump administration tariffs
